Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in Working CapitalDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeNon-cash Items
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MediWound (MDWD) Cash from Investing Activities: 2013-2025

Historic Cash from Investing Activities for MediWound (MDWD) over the last 10 years, with Sep 2025 value amounting to $4.4 million.

  • MediWound's Cash from Investing Activities rose 130.65% to $4.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$8.4 million, marking a year-over-year increase of 60.12%. This contributed to the annual value of -$8.4 million for FY2024, which is 75.53% up from last year.
  • Per MediWound's latest filing, its Cash from Investing Activities stood at $4.4 million for Q3 2025, which was up 230.99% from -$3.3 million recorded in Q2 2025.
  • MediWound's 5-year Cash from Investing Activities high stood at $4.8 million for Q4 2024, and its period low was -$14.3 million during Q3 2024.
  • Over the past 3 years, MediWound's median Cash from Investing Activities value was -$2.6 million (recorded in 2024), while the average stood at -$2.9 million.
  • Its Cash from Investing Activities has fluctuated over the past 5 years, first skyrocketed by 2,165.52% in 2022, then tumbled by 4,551.88% in 2023.
  • MediWound's Cash from Investing Activities (Quarterly) stood at -$116,000 in 2021, then soared by 2,165.52% to $2.4 million in 2022, then slumped by 4,551.88% to -$7.4 million in 2023, then surged by 76.03% to $4.8 million in 2024, then surged by 130.65% to $4.4 million in 2025.
  • Its last three reported values are $4.4 million in Q3 2025, -$3.3 million for Q2 2025, and $4.8 million during Q4 2024.